These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7849708)

  • 1. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene.
    Carbonara C; Longa L; Grosso E; Borrone C; Garrè MG; Brisigotti M; Migone N
    Hum Mol Genet; 1994 Oct; 3(10):1829-32. PubMed ID: 7849708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor.
    Green AJ; Johnson PH; Yates JR
    Hum Mol Genet; 1994 Oct; 3(10):1833-4. PubMed ID: 7849709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.
    Green AJ; Smith M; Yates JR
    Nat Genet; 1994 Feb; 6(2):193-6. PubMed ID: 8162074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas.
    Carbonara C; Longa L; Grosso E; Mazzucco G; Borrone C; Garrè ML; Brisigotti M; Filippi G; Scabar A; Giannotti A; Falzoni P; Monga G; Garini G; Gabrielli M; Riegler P; Danesino C; Ruggieri M; Magro G; Migone N
    Genes Chromosomes Cancer; 1996 Jan; 15(1):18-25. PubMed ID: 8824721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in tuberous sclerosis hamartomas.
    Sepp T; Yates JR; Green AJ
    J Med Genet; 1996 Nov; 33(11):962-4. PubMed ID: 8950679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
    Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
    Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions.
    Henske EP; Scheithauer BW; Short MP; Wollmann R; Nahmias J; Hornigold N; van Slegtenhorst M; Welsh CT; Kwiatkowski DJ
    Am J Hum Genet; 1996 Aug; 59(2):400-6. PubMed ID: 8755927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.
    van Slegtenhorst M; de Hoogt R; Hermans C; Nellist M; Janssen B; Verhoef S; Lindhout D; van den Ouweland A; Halley D; Young J; Burley M; Jeremiah S; Woodward K; Nahmias J; Fox M; Ekong R; Osborne J; Wolfe J; Povey S; Snell RG; Cheadle JP; Jones AC; Tachataki M; Ravine D; Sampson JR; Reeve MP; Richardson P; Wilmer F; Munro C; Hawkins TL; Sepp T; Ali JB; Ward S; Green AJ; Yates JR; Kwiatkowska J; Henske EP; Short MP; Haines JH; Jozwiak S; Kwiatkowski DJ
    Science; 1997 Aug; 277(5327):805-8. PubMed ID: 9242607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions.
    Wolf HK; Normann S; Green AJ; von Bakel I; Blümcke I; Pietsch T; Wiestler OD; von Deimling A
    Acta Neuropathol; 1997 Jan; 93(1):93-6. PubMed ID: 9006662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refined localization of TSC1 by combined analysis of 9q34 and 16p13 data in 14 tuberous sclerosis families.
    Janssen B; Sampson J; van der Est M; Deelen W; Verhoef S; Daniels I; Hesseling A; Brook-Carter P; Nellist M; Lindhout D
    Hum Genet; 1994 Oct; 94(4):437-40. PubMed ID: 7927344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.
    Niida Y; Stemmer-Rachamimov AO; Logrip M; Tapon D; Perez R; Kwiatkowski DJ; Sims K; MacCollin M; Louis DN; Ramesh V
    Am J Hum Genet; 2001 Sep; 69(3):493-503. PubMed ID: 11468687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberous sclerosis].
    Yamashita Y; Hino O
    Nihon Rinsho; 2000 Jul; 58(7):1455-9. PubMed ID: 10921323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberous sclerosis complex.
    DiMario FJ; Sahin M; Ebrahimi-Fakhari D
    Pediatr Clin North Am; 2015 Jun; 62(3):633-48. PubMed ID: 26022167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large deletion at the TSC1 locus in a family with tuberous sclerosis complex.
    Nellist M; Sancak O; Goedbloed MA; van Veghel-Plandsoen M; Maat-Kievit A; Lindhout D; Eussen BH; de Klein A; Halley DJ; van den Ouweland AM
    Genet Test; 2005; 9(3):226-30. PubMed ID: 16225402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberous sclerosis-related gene expression in normal and dysplastic brain.
    Vinters HV; Kerfoot C; Catania M; Emelin JK; Roper SN; DeClue JE
    Epilepsy Res; 1998 Sep; 32(1-2):12-23. PubMed ID: 9761305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the TSC1 gene account for a minority of patients with tuberous sclerosis.
    Ali JB; Sepp T; Ward S; Green AJ; Yates JR
    J Med Genet; 1998 Dec; 35(12):969-72. PubMed ID: 9863590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
    Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
    Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant pancreatic endocrine tumor in a child with tuberous sclerosis.
    Francalanci P; Diomedi-Camassei F; Purificato C; Santorelli FM; Giannotti A; Dominici C; Inserra A; Boldrini R
    Am J Surg Pathol; 2003 Oct; 27(10):1386-9. PubMed ID: 14508401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.